Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
about
An MRI study of amygdala in schizophrenia and psychotic bipolar disorderStructural brain alterations in individuals at ultra-high risk for psychosis: a review of magnetic resonance imaging studies and future directionsFrom Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of SchizophreniaTranslating the MAM model of psychosis to humansSchizophrenia in the spectrum of gene-stress interactions: the FKBP5 exampleNeuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophreniaA longitudinal study of alterations of hippocampal volumes and serum BDNF levels in association to atypical antipsychotics in a sample of first-episode patients with schizophreniaDifferential abnormalities of functional connectivity of the amygdala and hippocampus in unipolar and bipolar affective disorders.Human amygdala volume is predicted by common DNA variation in the stathmin and serotonin transporter genesNeuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal stateAltered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis.Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia.Amygdalocortical circuitry in schizophrenia: from circuits to molecules.Research in people with psychosis risk syndrome: a review of the current evidence and future directionsGray matter volumetric abnormalities associated with the onset of psychosis.Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: a review of structural MRI findingsAnnual research review: Current limitations and future directions in MRI studies of child- and adult-onset developmental psychopathologies.Schizophrenia: Evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiologyUse of magnetic resonance imaging in tracking the course and treatment of schizophrenia.Brain change trajectories that differentiate the major psychoses.Deconstructing psychosis with human brain imaging.Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies.Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic riskMedication effects in neuroimaging studies of bipolar disorder.Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.The structural neuroimaging of bipolar disorder.Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders.Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia.Evidence and implications for early intervention in bipolar disorder.White matter microstructure in schizophrenia: effects of disorder, duration and medicationAltered microstructure integrity of the amygdala in schizophrenia: a bimodal MRI and DWI study.White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosisDepressive Symptoms and Brain Metabolite Alterations in Subjects at Ultra-high Risk for Psychosis: A Preliminary Study.Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication.Cavum septum pellucidum and first-episode psychosis: A meta-analysis.Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who Do Not Remit: Findings from the Longitudinal Youth at Risk Study.Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophreniaAbnormal structure or function of the amygdala is a common component of neurodevelopmental disorders.The role of cannabinoid transmission in emotional memory formation: implications for addiction and schizophreniaSynaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location.
P2860
Q24606322-0033170A-17E2-4141-A012-8DDDDADDD38BQ24632737-B6486ADE-AAF5-4FF0-BF15-CC4DB8992971Q26744755-8C6A63EB-A4AB-4771-A020-7AC4F23ABCD8Q26860217-D5BF7D4D-F225-4CCE-976C-6E4DC538481EQ28081381-FD4848BD-9393-4D55-80CC-60893A7152CDQ28473742-96C7FD56-82BA-44D8-891B-92FF7428048CQ28539784-48FB6F41-3D01-4C65-AA6A-6761160E4DF6Q30369880-2979DA44-D692-4F6C-BB2F-56EA68DF2D7DQ30451308-4711F0EF-E71A-4A0F-A7EE-F4AFA5CCE122Q30466264-F2D7F9B7-EFD3-48DA-8212-D4AB169519A0Q30466268-94524AF0-A074-42D8-B4B8-0EF1884E9DE3Q30473410-11E04C1B-7F9E-4F9F-8CBD-42D80C08CEECQ30475524-F8803E79-A811-40C3-AFEE-CEA07F9FC040Q30475598-48EED825-D6C9-4F6E-8ABC-DC4547C4BD15Q30580970-8FB17836-77C7-4461-B55A-CB852C9BDEECQ30665421-F08EA02A-D3B4-44E4-897B-7A3D2D13744FQ30736435-D7FE9F79-3317-42B7-A16E-61A477949890Q30982690-72A52678-E692-41C2-9E62-EABA712BEB38Q31048455-AD98A3D4-D2F1-48CE-9285-B3C8B548B8E9Q31099010-0C334712-B60C-4AFE-96E2-31189EFB9DFBQ31114592-AED5F393-2331-472E-A525-B2A009A361D8Q31120585-79D863F9-4CDC-42DB-ABE7-EB84490FBA25Q31142901-F8367E4C-6041-4395-9518-8B56C95B36DFQ31145261-A3CCC2AF-5F5D-4315-BD2E-12699F341734Q33442474-4BC9B0F8-690D-4319-A4A0-6E293B4C26F6Q33550534-9ABCDF91-4C62-4107-B154-9E74B8E5F59CQ33555684-6396408B-48E8-49B0-ABF3-8C304E9BC312Q33563154-130A8839-6135-4BC2-A5E3-C9BECDBA77CDQ33568997-3430E799-6F25-46BE-A672-1C20E3676E5DQ33575068-8E92988A-61AC-427C-B14E-F18B7981CA97Q33575728-51A5C0EC-4A71-4A8B-9EAD-380920DA6A94Q33587494-69A339E2-A3E0-4DC0-A69E-47B6A810ABD4Q33600309-E8B68BD4-7399-4392-B68B-3355C3040B99Q33638277-DC20DE17-7408-4F6D-9D83-C2FB076F5865Q33699076-9D531BA4-E475-4A2E-8693-76FD7776B251Q33707483-731CEF66-F655-493C-BFF7-EFDA69334008Q33712210-AE94FDE7-286C-43FF-9510-963001DC490EQ33720054-A8D20D0B-2ECB-4C98-8B74-EAE65F45A416Q33820114-6B002FE6-F68F-41AF-A144-ADB350133F36Q33842202-62FA5441-3770-40A7-A815-B64ECE8C3A63
P2860
Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Hippocampal and amygdala volum ...... d ultra-high-risk individuals.
@ast
Hippocampal and amygdala volum ...... d ultra-high-risk individuals.
@en
Hippocampal and amygdala volum ...... d ultra-high-risk individuals.
@nl
type
label
Hippocampal and amygdala volum ...... d ultra-high-risk individuals.
@ast
Hippocampal and amygdala volum ...... d ultra-high-risk individuals.
@en
Hippocampal and amygdala volum ...... d ultra-high-risk individuals.
@nl
prefLabel
Hippocampal and amygdala volum ...... d ultra-high-risk individuals.
@ast
Hippocampal and amygdala volum ...... d ultra-high-risk individuals.
@en
Hippocampal and amygdala volum ...... d ultra-high-risk individuals.
@nl
P2093
P50
P921
P1433
P1476
Hippocampal and amygdala volum ...... d ultra-high-risk individuals.
@en
P2093
Dennis Velakoulis
Michael T H Wong
Patricia Desmond
Patrick D McGorry
Tina Proffitt
Warrick Brewer
P304
P356
10.1001/ARCHPSYC.63.2.139
P407
P577
2006-02-01T00:00:00Z